ALPLA acquires all shares from joint venture partner Taba

ALPLA fully integrates the site in Egypt into the Group with the acquisition of all shares from joint venture partner Taba. ALPLA is now one of the country's leading manufacturers in standard packaging for pharmaceutical products in the region.

New articles

Premiere at the FCE Pharma 2024

BrasALPLA and BrasALPLApharma at Latin America's largest pharmaceutical and cosmetics trade fair in 2024.

Successful collaboration and exciting prospects - ALPLApharma and Inden Pharma at Pharmapack 2024

ALPLApharma and Inden Pharma will be exhibiting together at the Pharmapack 2024 in Paris.

Expansion: ALPLA and Inden Pharma form joint venture

Specialists in pharmaceutical packaging ALPLA and Inden Pharma combine expertise and increase capacities.

ALPLA expanding its manufacturing technology for OTC packaging

ALPLApharma is expanding its OTC container production capacities. In addition to the IBM technology it will henceforth also offer its...

Packaging specialist ALPLA’s pharma division growing

Further expansion of ALPLApharma business division due to acquisition of Polish company APON.

ALPLA at trade shows and exhibitions

We would be delighted to welcome you to our stand for a personal consultation during your trade show attendance.

CRC just ONE: a new generation of child-resistant closures

At the CPhI worldwide event in Milan (9–11 November 2021), ALPLApharma will present its latest developments in the field of...

ALPLApharma – a new global provider of innovative pharmaceutical packaging

From 5 to 7 November 2019, ALPLA will be presenting ALPLApharma, its new brand, at the CPhI trade show in...

Growing big on the packaging market for pharmaceutical products

An acquisition can be tricky. The acquired company is being integrated into the other company – from a technical, but...

ALPLA purchases Argo S.A.: transaction completed

Centre of excellence for pharmaceutical packaging created in Greece

ALPLA expands in south-eastern Europe

Acquisition produces a new centre of excellence for the pharmaceutical market